Medical Device News Magazine

DJO Announces New Stemless Shoulder Offering – the AltiVate® Anatomic CS EDGE™ – New System Design Provides a More Bone-Baring Solution That Is Less Invasive Than Traditional Shoulder Stem Offerings

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 30, 2020

DJO today announced the launch of the canal-sparing AltiVate® Anatomic CS EDGE™ Shoulder System.

DJO notes the new system is designed to provide a more bone-sparing solution that is less invasive than traditional shoulder stem offerings.

DJO notes around 67,000 anatomic total shoulder arthroplasty procedures are done each year in the United States, and that number is expected to grow by 8.6% over the next two years.1 Through the introduction of newer tissue-sparing technologies like short stem and stemless shoulder implants, future growth in the US shoulder arthroplasty market is expected to be driven by increasing penetration into the younger patient population.2

“Our goal is to continue to drive innovation and bring market-leading products to patients; the addition of AltiVate Anatomic CS EDGE delivers the next advancement in our shoulder solutions portfolio,” said Louis Vogt, Vice President of Sales and Marketing, DJO Surgical®. “With the growing active patient population, the CS EDGE offers a unique bone-conserving solution to surgeons to address the needs of their anatomic arthroplasty patients.”

The design of the AltiVate Anatomic CS EDGE is based off a humeral fit analysis that was conducted to help optimize fit of peripherally targeted fins within the humeral metaphysis.3 The AltiVate Anatomic CS EDGE features a canal-sparing, 3-fin humeral stem with unique serrated fin tips, allowing surgeons the option to use the implant to cut into the bone. The system also incorporates P2™, a proprietary titanium porous coating that aids in the apposition of bone for excellent in-growth performance and an enhanced press-fit implantation.4

“As the first surgeon to use the AltiVate Anatomic CS EDGE, I was impressed by the press-fit implantation offered by this system. During insertion, you can feel the exceptional primary fixation and stability the implant design offers, which is critical in stemless applications,” said Dr. T. Bradley Edwards, Fondren Orthopedic Group in Houston, TX. “The innovative design of the CS EDGE system provides the best stemless implant fixation available in today’s market. In addition, the streamlined instrumentation creates efficiency, resulting in shorter operative time compared to other traditional stem systems I’ve used.”

Compatible with the AltiVate Anatomic e+™ glenoid component featuring patented Drop-and-Go® technology for immediate fixation,5 the CS EDGE™ Shoulder System gives surgeons the cutting edge needed in anatomic total shoulder arthroplasty solutions.

“I’ve been using the AltiVate Anatomic System for years, and I’m excited about the addition of the stemless product offering. The system maintains the intuitive and easy-to-use qualities that are characteristic of the AltiVate Anatomic brand,” said Dr. Jonathan Levy, Holy Cross Orthopedic Institute in Ft. Lauderdale, FL. “The immediate fixation achieved by the CS EDGE’s novel fin design and P2™ porous coating is quite remarkable, allowing me to confidently use the implant in patients of all ages. The CS EDGE has helped me to precisely replicate anatomy, minimize bone and blood loss during surgery, and facilitate shoulder arthroplasty in the outpatient setting with an efficient surgical workflow.”

The AltiVate® Anatomic CS EDGE™ is an important addition to DJO’s industry-leading AltiVate® Extremity Solutions product portfolio.


References

1 Smart TRAK® – Anatomic Total Shoulder Replacement Procedures, 2019

2 Smart TRAK® Shoulder Replacement https://app.smarttrak.com/markets/qs/d5ba9c8c85ec851cac1002a5f5bc1f81

3,4,5 Data on file at DJO®. Laboratory testing does not necessarily indicate clinical performance.

Dr. T. Bradley Edwards and Dr. Jonathan Levy are paid consultants for DJO®.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”